We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

GE Healthcare Acquire Biosafe

News   Jul 16, 2016

 
GE Healthcare Acquire Biosafe
 
 
 

RELATED ARTICLES

Phase 1 Trial Shows Cell Therapy Could Be a Feasible Treatment for Stroke Patients

News

Researchers have reported that bone marrow cells used to treat ischemic stroke in an expanded Phase I trial were not only safe and feasible, but also resulted in enhanced recovery compared to a matched historical control group.

READ MORE

Transplanted Brain Stem Cells Survive in Mice Without Anti-rejection Drugs

News

In experiments in mice, Johns Hopkins Medicine researchers have developed a way to successfully transplant certain protective brain cells without the need for lifelong anti-rejection drugs.

READ MORE

Knotty Problem of Cell Reprogramming Solved

News

Researchers have found a way to repurpose cells more reliably than current methods by untangling DNA, clearing a roadblock in regenerative medicine to reach treatments for a wide range of diseases.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Cell Science

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE